Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide in saline sinus irrigation for chronic rhinosinusitis
NCT02696850Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2016
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide in chronic rhinosinusitis (CRS), sponsored by Washington University School of Medicine. Primary endpoint: Sino-Nasal Outcome Test at 4 weeks. Started Jan 2016; status: completed.
02
Drugs
budesonide
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT02696850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02696850.